ECEESPE2025 ePoster Presentations Bone and Mineral Metabolism (142 abstracts)
1Hedi Chaker University Hospital, Endocrinology Department, Sfax, Tunisia
JOINT3398
Introduction: Familial hypocalciuric hypercalcemia (FHH), also known as Marx syndrome, is a benign hereditary condition with autosomal dominant transmission. Here, we describe a case of FHH diagnosed in the context of the management of Sjögrens syndrome.
Case Report: A 41-year-old female patient with no significant medical history presented with ocular and oral dryness. The diagnosis of Sjögrens syndrome was confirmed based on a Grade 4 Chisholm lymphocytic sialadenitis found on labial biopsy and the presence of positive anti-SSA antibodies. A phosphocalcium assessment repeatedly showed hypercalcemia (2.72.83 mmol/l) with normal phosphatemia and alkaline phosphatases, along with hypocalciuria confirmed on multiple occasions (0.451.3 mmol/24h). Given this moderate and asymptomatic hypercalcemia, an etiological investigation was conducted, ruling out:Primary hyperparathyroidism (normal PTH, unremarkable ultrasound), Multiple myeloma (normal serum immunoelectrophoresis), Sarcoidosis (normal angiotensin-converting enzyme levels), Drug-induced hypercalcemia (no relevant medication history) The presence of hypocalciuria further supported the diagnosis of familial hypocalciuric hypercalcemia (FHH).
Discussion: Renal involvement in Sjögrens syndrome can lead to hypercalciuria due to tubular dysfunction. The uniqueness of this case lies in the unexpected finding of hypocalciuria, which, after an extensive workup, was attributed to FHH. FHH is associated with an inactivating mutation of the calcium-sensing receptor (CaSR) gene, located on chromosome 3, necessitating screening of other family members